Syringe drug mixing unit
Patent Information
- Application Number
- JP2023514427
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-09-07
- Filing Date
- 2021-09-03
- Publication Date
- 2024-11-06
- Estimated Expiration
- 2041-09-03
AI Technical Summary
【0030】 本発明の実施例によるシリンジ用薬剤混合ユニットは、希釈液が備えられたバイアルに気密(air tightness)結合することにより、混合される異種薬品が外部の空気と接触することのない密閉状態で混合されるようにすることにより、薬品の汚染可能性を大きく下げることができる。
Smart Images

Figure 0007578324000001 
Figure 0007578324000002 
Figure 0007578324000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a drug mixing unit, and more particularly to a drug mixing unit for mixing different drugs for use in connection with a syringe. [Background technology]
[0002] A syringe is a tool used to inject or withdraw liquid substances. It is common for the liquid substance to be injected to be prepared in advance and then filled into a syringe before injection, but some drugs can decompose quickly in solution and lose their efficacy, making it difficult to prepare the liquid substance in advance, so they may be prepared in liquid form just before injection. In addition, when refrigeration or special packaging is required for the stability of drug storage, the liquid is mixed just before injection.
[0003] In the case of drugs injected through a syringe, they must be mixed in a state that is isolated from the outside air to prevent contamination and oxidation, and the mixed liquid must be filled into the syringe in a state that is isolated from the outside air. In particular, most drugs are manufactured in a solid form such as powder or tablet to ensure storage safety, but a complicated process must be carried out in order to reconstitute the solid drug into a liquid dosage form before administration, and there are risks such as drug contamination and air bubble generation during the process.
[0004] Prior documents relating to syringes capable of simultaneously injecting two or more types of medicaments include Patent Documents 1 and 2. All of these technologies have a structure in which a second small-diameter syringe is inserted into a first large-diameter syringe, a piston inside the first large-diameter syringe is connected to the discharge port of the second small-diameter syringe, and the liquid medicament contained in the second small-diameter syringe is supplied to and mixed with the powder inside the first large-diameter syringe.
[0005] However, according to the prior art document, a second syringe is inserted inside one larger syringe, and a sufficiently sealed individual space is not provided for each drug, but a drug mixing space is provided by combining the syringes. This results in low storage stability of the drugs, and the operation of the second syringe may affect the operation of the first syringe, increasing the possibility of malfunction.
[0006] In addition, when the different drugs to be injected are liquid, they can be mixed at a fast speed, but when solid drugs such as powders or tablets are mixed with a diluent, they need to be thoroughly shaken to mix, and there is a possibility that air bubbles will be formed during the shaking process.
[0007] A method has also been proposed in which a syringe filled with a diluent is attached to a separate container in which powders or tablets are stored, allowing for immediate injection into the body. However, as mentioned above, powder or tablet-like medicines are difficult to dissolve sufficiently, and the needle can become clogged.
[0008] When the diluent is injected through a syringe, the powder or tablet-like medicine that is not fully dissolved may block the needle of the syringe and inhibit the flow of the medicine. In order to fully dissolve the powder medicine just before injection, it is possible to increase the contact path and time between the diluent and the powder medicine to ensure sufficient dissolution time. However, even in this case, it is difficult to be certain that the powder medicine will be fully dissolved. In particular, if the powder or granular material that has blocked the needle is dissolved by the diluent and the drug movement path of the needle is suddenly opened, the medicine may be injected at an excessively fast speed, and the needle may be separated from the syringe due to pressure when the plunger is operated with excessive pressure. Furthermore, when injection is required with a separate container connected to the syringe, if sufficient space for the syringe to approach is not secured, ease of use may be greatly reduced. [Prior art documents] [Patent documents]
[0009] [Patent Document 1] Korean Patent Publication No. 10-2014-0017947 [Patent Document 2] Korean Patent Publication No. 10-2011-0041826 Summary of the Invention [Problem to be solved by the invention]
[0010] The drug mixing unit for a syringe according to the embodiment of the present invention aims to significantly reduce the possibility of drug contamination by allowing different drugs to be mixed in a sealed state without contact with the outside air.
[0011] The drug mixing unit for syringes according to an embodiment of the present invention aims to increase the convenience of drug mixing by mixing a diluent moved by the negative pressure generated by operating a syringe plunger with a drug already stored in the drug mixing unit, moving to the cylinder of the syringe, and filling the syringe.
[0012] The drug mixing unit for a syringe according to an embodiment of the present invention aims to provide an extended movement path that ensures sufficient time for the powdered drug pre-stored inside to move and be mixed with the diluent moved by the negative pressure generated by operating the syringe plunger.
[0013] The pharmaceutical mixing unit for a syringe according to an embodiment of the present invention aims to allow a sufficient amount of diluent to be mixed with a powdered pharmaceutical and moved into the barrel of a syringe even with a small amount of negative pressure generated by operating a syringe plunger.
[0014] The objects of the present invention are not limited to those mentioned above, and other objects not mentioned will be clearly understood by those having ordinary skill in the art to which the present invention pertains from the following description. [Means for solving the problem]
[0015] To solve the above technical problems, a drug mixing unit according to one aspect of the present invention includes a barrel member having a first flow path through which a drug solution is drawn in; and a plug member having an insertion portion to be inserted into the barrel member, a second flow path through which a mixed drug is drawn out inside the insertion portion, and a through hole connected to the second flow path formed on one side of the insertion portion; the plug member is coupled to the barrel member to form a predetermined drug mixing space, and the drug mixing space is provided with drugs to be mixed with the drug solution drawn in through the first flow path to form the mixed drug, and a third flow path is formed on the inner side of the barrel member for the mixed drug to move from the drug mixing space to the through hole.
[0016] Here, the barrel member may include a protruding spike needle that forms a first flow passage on one outer surface thereof, and the spike needle may form at least one opening connected to the first flow passage on the outer surface.
[0017] Here, the plug member may include a protruding coupling portion that defines the second flow passage.
[0018] Here, the drug mixing space forms a spiral path from a predetermined position separated from the first flow path to the third flow path, and the spiral path can be formed by a continuous partition portion provided from the inner bottom of the barrel member to contact the outer bottom surface of the insertion portion of the plug member.
[0019] Here, the through-hole and the third flow passage may be disposed at a predetermined distance from each other.
[0020] Here, the drug mixing unit may further include a protective portion into which a barrel member for isolating the first flow path from the outside air is inserted and supported, and an undercap in which the protective portion and a gripping portion for fixing and supporting an upper cap of a vial in which the drug solution is stored are integrally formed.
[0021] Here, the drug mixing unit may further include an upper cap for blocking the second flow path from the outside air.
[0022] Here, the second flow path may be configured to couple with a syringe that provides a negative pressure through which the medical fluid is drawn.
[0023] Here, the medicine mixing unit may further include a rubber stopper into which the spike needle is inserted and supported to block the first flow path from the outside air.
[0024] Here, the first flow path, the second flow path and the third flow path may be provided so as not to be directly connected to each other.
[0025] Here, the first flow passage is formed to protrude at a predetermined height from the inner bottom of the barrel member, but may be formed at a height lower than the lower end surface of the insertion portion of the plug member.
[0026] Here, the medicine may be a liquid medicine, a powder medicine or a granular medicine.
[0027] Here, the plug member and the barrel member may be coupled by a projection and recess for mutual support, or may be coupled by a rotational coupling using a screw thread.
[0028] Here, the plug member may further include a support portion provided to have an outer diameter larger than that of the insertion portion, and may further include a silicone ring member between the insertion portion and the support portion of the plug member to block the plug member from the outside air when the plug member is coupled to the barrel member.
[0029] Here, the inner diameter of the through hole may be larger than the inner diameter of the first flow path and smaller than the inner diameter of the second flow path. Effect of the Invention
[0030] The drug mixing unit for syringes according to an embodiment of the present invention is air tightly coupled to a vial containing a diluent, allowing different drugs to be mixed in a sealed state without coming into contact with the outside air, greatly reducing the possibility of drug contamination.
[0031] The drug mixing unit for syringes according to an embodiment of the present invention can increase the convenience of drug mixing by allowing the diluent moved by the negative pressure generated by operating the syringe plunger to be mixed with the drug pre-stored in the drug mixing unit and moved to the cylinder of the syringe, thereby filling the syringe.
[0032] A drug mixing unit for a syringe according to an embodiment of the present invention can provide an extended travel path that ensures sufficient time for a drug, such as a powder or liquid drug, pre-stored inside, to travel along with a diluent or other drug liquid moved by the negative pressure generated by operating the syringe plunger and be mixed to a homogenous concentration.
[0033] The drug mixing unit for a syringe according to an embodiment of the present invention increases user convenience by allowing sufficient diluent to be supplied through the needle even with the small negative pressure generated by operating the syringe plunger, and can minimize drug residue by mixing with powdered drug and transferring it to the syringe barrel.
[0034] The effects of the present invention are not limited to those described above, and other effects not mentioned will be clearly understood by those having ordinary skill in the art to which the present invention pertains from the following description. [Brief description of the drawings]
[0035] [Figure 1] FIG. 1 is a diagram showing a drug mixing unit according to an embodiment of the present invention. [Diagram 2] FIG. 2 is a diagram showing a state where a barrel member and a plug member constituting a drug mixing unit according to an embodiment of the present invention are separated and joined together. [Diagram 3] FIG. 3 is a perspective view showing the inside of the barrel member. [Figure 4] FIG. 4 is a diagram illustrating a side view of a protruding spike needle formed on a barrel member. [Diagram 5] FIG. 5 is a diagram illustrating a rear cross section and a side view of a spike needle. [Figure 6] FIG. 6 is an exploded perspective view and a side view of the spike needle as viewed from the rear. [Figure 7] FIG. 7 is a cross-sectional view illustrating a state in which the barrel member and the plug member are separated. [Figure 8] FIG. 8 is a diagram illustrating an example of how the first flow path, the second flow path, and the third flow path are arranged. [Figure 9] FIG. 9 shows (a) the barrel member and the gripping part for fixing and supporting the upper cap of the vial joined together, and (b) the rubber stopper into which the barrel member and spike needle are inserted and supported and the protective part into which the barrel member is inserted and supported joined together. [Figure 10] FIG. 10 shows a drug mixing unit according to an embodiment of the present invention coupled to a syringe and with the rubber stopper and protective part removed before coupling to a vial. [Figure 11] FIG. 11 is a diagram illustrating a medicine mixing unit according to an embodiment of the present invention, a gripping part, a protective part, a rubber stopper, and a syringe. [Figure 12] FIG. 12 is a time-series diagram illustrating how the medicine mixing unit according to the embodiment of the present invention is coupled to a vial after the gripper, protective part, rubber stopper, and upper cap are coupled together. [Figure 13] FIG. 13 is a diagram illustrating, in a time sequence, how the drug mixing unit according to an embodiment of the present invention is coupled to a vial with a gripper attached thereto, the drug liquid moving into the syringe cylinder, and how the mixed drug is coupled to a stopper member for blocking outside air before final use. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0036] A drug mixing unit according to one aspect of the present invention for solving the above technical problem includes a barrel member having a first flow path through which a drug solution is drawn in; and a plug member having an insertion portion to be inserted into the barrel member, a second flow path through which a mixed drug is drawn out inside the insertion portion, and a through hole connected to the second flow path formed on one side of the insertion portion; the plug member is coupled to the barrel member to form a predetermined drug mixing space, and the drug mixing space is provided with drugs to be mixed with the drug solution drawn in through the first flow path to form the mixed drug, and a third flow path is formed on an inner side of the barrel member through which the mixed drug moves from the drug mixing space to the through hole, and the plug member is coupled to the barrel member to form a predetermined drug mixing space, and a drug mixing space is provided with a drug to be mixed with the drug solution drawn in through the first flow path to form the mixed drug, and a third flow path is formed on an inner side of the barrel member to move the mixed drug from the drug mixing space to the through hole, and the plug member is coupled to the barrel member to form a predetermined drug mixing space. the plug member has a protruding spike needle forming a first flow path on one outer surface, the spike needle has a plurality of openings connected to the first flow path on its outer surface, the first flow path is provided to have a wider radius as it approaches the inner bottom surface of the barrel member, the drug mixing space forms a spiral path from a predetermined position separated from the first flow path to the third flow path, the spiral path is formed by a continuous partition portion provided from the inner bottom of the barrel member to contact the outer bottom surface of the insertion portion of the plug member, the second flow path is coupled to a syringe providing a negative pressure for drawing in the drug solution, and the first, second and third flow paths are provided so as not to be directly connected to each other.
[0037] Here, the plug member may include a protruding coupling portion that defines the second flow passage.
[0038] Here, the through-hole and the third flow passage may be disposed at a predetermined distance from each other.
[0039] Here, the drug mixing unit may further include a protective portion into which a barrel member for isolating the first flow path from the outside air is inserted and supported, and an undercap in which the protective portion and a gripping portion for fixing and supporting an upper cap of a vial in which the drug solution is stored are integrally formed.
[0040] Here, the drug mixing unit may further include an upper cap for blocking the second flow path from the outside air.
[0041] Here, the medicine mixing unit may further include a rubber stopper into which the spike needle is inserted and supported to block the first flow path from the outside air.
[0042] Here, the first flow passage is formed to protrude at a predetermined height from the inner bottom of the barrel member, but may be formed at a height lower than the lower end surface of the insertion portion of the plug member.
[0043] Here, the medicine may be a liquid medicine, a powder medicine, or a granular medicine.
[0044] Here, the plug member and the barrel member may be coupled by a projection and recess for mutual support, or may be coupled by a rotational coupling using a screw thread.
[0045] Here, the plug member may further include a support portion provided to have an outer diameter larger than that of the insertion portion, and may further include a silicone ring member between the insertion portion and the support portion of the plug member to block the plug member from the outside air when the plug member is coupled to the barrel member.
[0046] Here, the inner diameter of the through hole may be larger than the inner diameter of the first flow path and smaller than the inner diameter of the second flow path. EXAMPLES
[0047] The objectives and effects of the present invention, as well as technical configurations for achieving them, will become apparent with reference to the following detailed embodiments together with the accompanying drawings. In the description of the present invention, if it is determined that a detailed description of a known function or configuration may unnecessarily obscure the gist of the present invention, the detailed description will be omitted. The terms used below are terms defined for the description of the embodiments of the present invention, and may vary depending on the intention or practice of a user or operator.
[0048] However, the present invention is not limited to the embodiments disclosed below, and may be realized in various different forms. However, the embodiments are provided to make the disclosure of the present invention complete and to fully inform those skilled in the art of the present invention of the scope of the invention, and the present invention is defined only by the claims. Therefore, the definition should be based on the contents of the entire specification.
[0049] Throughout the specification, when a part "includes" or "has" a certain component, this does not mean excluding other components, but may further include other components, unless otherwise specified. Furthermore, the terms "unit", "section" or "module" used in the specification mean a unit that processes at least one function or operation, which may be realized by hardware, software, or a combination of hardware and software.
[0050] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, a drug mixing unit for a syringe according to an embodiment of the present invention will be specifically described with reference to the accompanying drawings.
[0051] Fig. 1 is a diagram showing a drug mixing unit 1000 according to an embodiment of the present invention, and Fig. 2 is a diagram showing a state in which a barrel member 100 and a plug member 200 constituting the drug mixing unit 1000 according to an embodiment of the present invention are separated and coupled together. The plug member 200 and the barrel member 100 constituting the drug mixing unit 1000 may be coupled together by a projection and recess for mutual coupling support, or may be coupled together in a rotation coupling manner by a screw thread.
[0052] FIG. 1 shows a state in which a plug member 200 and a barrel member 100 are joined and supported to each other by their projections and recesses in a fitting manner.
[0053] Referring to FIG. 1, a drug mixing unit 1000 according to one embodiment of the present invention includes a barrel member 100 having a first flow path 10 through which a drug solution is drawn in; and a plug member 200 having an insertion portion 230 to be inserted into the barrel member 100, a second flow path 20 through which a mixed drug is drawn out inside the insertion portion 230, and a through hole 220 connected to the second flow path 20 formed on an outer surface of the insertion portion 230; the plug member 200 is combined with the barrel member 100 to form a predetermined drug mixing space, and the drug mixing space is provided with drugs to be mixed with the drug solution drawn in through the first flow path 10 to form a mixed drug, and a third flow path 30 is formed on an inner surface of the barrel member 100 through which the mixed drug moves from the drug mixing space to the through hole 220.
[0054] The plug member 200 includes an insertion portion 230 for being inserted into the barrel member 100. A second flow passage 20 is formed inside the plug member 200, and is connected to a through hole 220 formed in the insertion portion 230. Referring to FIG. 2, it can be seen that the through hole 220 is formed on a side surface of the insertion portion 230.
[0055] In this case, if the through-hole 220 is formed to be connected to the second flow path 20, it may be formed in a shape penetrating from one side of the insertion part 230 to the point where it meets the second flow path 20 or to the other side opposite to the one side. However, without being limited thereto, in the case of airtight connection between the first flow path 10, the drug mixing space, the third flow path 30 and the second flow path 20, a plurality of through-holes 220 may be formed.
[0056] When the mixed drug moves, the inner diameter of the through-hole 220 may be formed to be larger than the inner diameter of the first flow path 10 and smaller than the inner diameter of the second flow path 20. This allows a constant amount of the drug solution and / or the mixed drug to flow smoothly from the first flow path 10 to the second flow path 20 by maintaining the suction pressure of the drug solution such as a diluent stored in a vial or the like.
[0057] Referring to FIG. 2, when the barrel member 100 and the plug member 200 are coupled to each other, the drug mixing space is formed between the lower end surface of the insertion portion 230 of the plug member 200 and the inner surface of the barrel portion.
[0058] The drug mixing space forms a spiral path from a predetermined position separated from the first flow path 10 to the third flow path 30, and the spiral path can be formed by a continuous partition portion 120 arranged from the inner bottom surface 110 of the barrel member 100 to contact the outer bottom surface of the insertion portion 230 of the plug member 200.
[0059] Fig. 3 is a perspective view showing the inside of the barrel member 100. The drug mixing space will be described in more detail with reference to Fig. 3. With reference to Fig. 3, it can be seen that the partition 120 forms a continuous spiral path adjacent to the end of the first flow path 10 formed in the barrel member 100.
[0060] The partition 120 forming the spiral path may come into contact with the lower end surface of the insertion portion 230 of the plug member 200 to form an airtight passage through which the drug solution supplied from the first flow path 10 can move by the negative pressure transmitted from the through hole 220. A drug to be mixed with the drug solution introduced through the first flow path 10 may be provided on the spiral path in advance. Thus, such a spiral path may be used as a drug mixing space in which the drug solution and the previously prepared drug are mixed. The drug solution may be a diluent for diluting the drug, but is not limited thereto, and any drug that can function as a solvent capable of dissolving the drug may be used without limitation.
[0061] Meanwhile, the drug may be a liquid drug, a powdered drug, or a granular drug. For example, the drug may be a freeze-dried powdered or granular drug. The freeze-dried drug may be solid enough to not flow out through the first flow path 10. Alternatively, although not shown, a barrier membrane may be provided at the end of the first flow path 10 to prevent the stored drug from flowing out. In such a case, the barrier membrane may be made of a material that dissolves in the drug solution but does not affect the efficacy or effect of the mixture of the drug solution and the drug.
[0062] As another example, the first flow passage 10 may be formed to protrude from the inner bottom surface 110 of the barrel member 100 at a predetermined height, but may be formed at a height lower than the lower end surface of the insertion portion 230 of the plug member 200. That is, the end portion of the first flow passage 10 may protrude at a height lower than the partition portion 120 to reach the height of the end portion of the first flow passage 10, thereby preventing the drug from being discharged into the first flow passage 10. Since the first flow passage 10 is a path through which the drug solution stored in a vial or the like moves due to negative pressure, even if the height formed by protruding from the inner bottom surface 110 of the barrel member 100 is formed to be almost close to the height of the partition portion 120, the drug may move to the spiral path in which it is stored.
[0063] Next, the first flow path 10 is used as a passage through which a medicinal liquid capable of dissolving a drug moves. The first flow path 10 is formed inside the spike needle 140, and can serve as a passage for the medicinal liquid up to the inner bottom surface 110 of the barrel member 100.
[0064] The spike needle 140 and the first flow path 10 will be described in detail below with reference to Figures 4 to 6. Although the spike needle 140 can be formed integrally with the barrel member 100, for convenience of explanation, the spike needle 140 will be described in a virtual separated state.
[0065] In the drug mixing unit 1000 according to an embodiment of the present invention, the barrel member 100 is provided with a protruding spike needle 140 that forms a first flow path 10 on one outer surface, and the spike needle 140 may form at least one or more openings 40a, 40b, 40c... connected to the first flow path 10 on the outer surface.
[0066] FIG. 4 is a diagram illustrating a side view of the protruding spike needle 140 formed on the barrel member 100, FIG. 5 is a diagram illustrating a rear cross-section and a side view of the spike needle 140, and FIG. 6 is an exploded oblique view and a side view of the spike needle 140 seen from the rear direction.
[0067] 4, it can be seen that the openings 40a, 40b, 40c... are formed on the outer surface of the spike needle 140. At least one opening 40a, 40b, 40c... may be formed, and the medicinal liquid drawn in through the openings 40a, 40b, 40c... moves to the first flow path 10 and moves to the medicine mixing space.
[0068] 5, it can be seen that the radius R1 of the first flow passage 10 into which the medicinal liquid supplied from the openings 40a, 40b, 40c... formed on the outer surface of the spike needle 140 is drawn is smaller than the radius R2 of the first flow passage 10 adjacent to the inner bottom surface 110 of the barrel member 100. This is to allow the medicinal liquid to be evenly delivered to the medicinal liquid prepared in advance in the medicinal liquid mixing space by drawing in a large amount of medicinal liquid through the openings 40a, 40b, 40c... while maintaining a constant pressure, but by allowing the pressure to drop before reaching the medicinal liquid.
[0069] Referring to FIG. 6(a), three openings 40a, 40b, and 40c are formed and are provided as a passage for drawing in the medicinal liquid. The medicinal liquid moves under high pressure by entering the narrow inlet passage of the first flow path 10, and the discharge pressure can be reduced by discharging into the wide outlet passage to be delivered to the medicine stored in advance, thereby allowing the medicinal liquid to move smoothly.
[0070] 6(b), the openings 40a, 40b, 40c... formed at about 1 / 3 to 1 / 2 the length of the spike needle 140 can be seen between the tip of the spike needle 140 and the openings 40a, 40b, 40c.... This is to allow a large amount of the medicinal liquid to be stably transferred to the medicine mixing space in a constant amount by transferring the medicinal liquid to the first flow path 10. The lower end i of the spike needle 140 and the body ii extending from the lower end to the openings 40a, 40b, 40c... can be formed to an appropriate length depending on the capacity of the vial in which the medicinal liquid is stored. In this case, it is preferable that the lower end i is formed to have a wider diameter than the body ii to ensure airtightness when combined with a vial, etc.
[0071] Next, the plug member 200 of the medicine mixing unit 1000 according to the embodiment of the present invention will be described.
[0072] 1, it can be seen that a through hole 220 is formed on the outer surface of the insertion portion 230 of the plug member. The through hole 220 is connected to the second flow path 20 formed inside the plug member 200, so that the drugs mixed in the drug mixing space are transported to the second flow path 20.
[0073] As described above, the drug solution is drawn into the first flow path 10 through the openings 40a, 40b, 40c... and moves to the drug mixing space, the mixed drug in the drug mixing space passes through the third flow path 30 and is transported to the through hole 220, and the mixed drug (or mixed drug) transported from the through hole 220 can be withdrawn via the second flow path 20.
[0074] The first flow path 10, the second flow path 20, and the third flow path 30 through which the drug solution, the mixed drug, etc. move may be provided so as not to be directly connected to each other. Hereinafter, a detailed description will be given with reference to Figs. 7 and 8.
[0075] FIG. 7 is a diagram illustrating a cross section of the barrel member 100 and the plug member 200 when they are separated, and FIG. 8 is a diagram illustrating the arrangement of the first flow path 10, the second flow path 20, and the third flow path 30.
[0076] 7(a), a second passage 20 formed inside the plug member 200 and a through hole 220 connected to the second passage 20 can be seen. The plug member 200 further includes a support portion 240 provided to have a larger outer diameter than the insertion portion 230, and may further include a silicone ring member between the insertion portion 230 and the support portion 240 of the plug member 200 for blocking outside air when the plug member 200 is coupled to the barrel member 100.
[0077] As described above, when the insertion part 230 is inserted into the barrel member 100, the support part 240 and the seating part 130 of the barrel part are fastened together, and the insertion part 230 and the partition part 120 on the inner surface of the barrel part form a drug mixing space. In this case, the lower surface of the support part 240 may further include a groove 231 into which a silicone member is inserted and fixed for airtight connection with the seating part 130.
[0078] 8(a), it can be seen that the through-hole 220 is formed apart from the inner surface of the barrel member 100. That is, the outer surface between the through-hole 220 and the lower surface of the insertion part 230 is abutted and coupled without a gap, and the through-hole 220 is provided to form a predetermined gap with the inner surface of the barrel member 100.
[0079] 2 and 8(b), a third flow path 30 for moving mixed drugs from the drug mixing space to the through-hole 220 can be seen.
[0080] 8(b), the through-hole 220 and the third flow passage 30 may be disposed at a predetermined distance apart. Rather than directly connecting the through-hole 220 and the third flow passage 30, it is preferable that the mixed chemicals moving through the third flow passage 30 fill all of the predetermined gaps formed between the outer surface of the upper part of the through-hole 220 of the insertion part 230 and the inner surface of the barrel member 100 before moving to the through-hole 220, thereby providing a sufficient time required for mixing.
[0081] The gap may maintain the negative pressure provided by the syringe S through the through-hole 220 due to the airtightness ensured by the silicon member. Also, the second flow path 20 may be configured to be coupled to the syringe S that provides the negative pressure for drawing in the drug solution.
[0082] The drug mixing unit 1000 according to the embodiment of the present invention may be used in combination with a syringe S, and for this purpose, the plug member 200 may include a protruding coupling portion 250 that forms the second flow path 20. The protruding coupling portion 250 is coupled to the syringe S, and allows negative pressure generated by the movement of the plunger of the syringe S to be transmitted via the second flow path 20.
[0083] The drug mixing unit 1000 according to an embodiment of the present invention may further include a protective part 3000 into which the barrel member 100 is inserted and supported, which is provided to isolate the first flow path 10 from the outside air, and an undercap in which the protective part 3000 and a gripping part 2000 for fixing and supporting an upper cap of a vial in which a drug solution is stored are integrally formed.
[0084] FIG. 9 shows the combination of the drug mixing unit 1000 and the gripping part 2000 for fixing and supporting the upper cap of the vial, and the combination of the barrel member 100, the rubber stopper 4000 into which the spike needle 140 is inserted and supported, and the protective part 3000 into which the barrel member 100 is inserted and supported.
[0085] 9(a), there can be seen a protective part 3000 into which the barrel member 100 is inserted and supported, and an undercap in which the protective part 3000 and a gripping part 2000 for fixing and supporting an upper cap of a vial in which a medicinal liquid is stored are integrally formed. The gripping part 2000 grips the outer uneven part of the vial, so that the spike needle 140 can be stably fastened to the vial.
[0086] 9(b), it can be seen that the medicine mixing unit 1000 according to the embodiment of the present invention is combined with a rubber stopper 4000 into which the spike needle 140 is inserted and supported to block the first flow path 10 from the outside air. The spike needle 140 of the medicine mixing unit 1000 forms wide openings 40a, 40b, 40c... connected to the first flow path 10, so that the spike needle 140 can be blocked from the outside air using the rubber stopper 4000 to prevent the medicine inside from leaking out.
[0087] 10 shows a state where the medicine mixing unit 1000 according to the embodiment of the present invention is coupled to a syringe S, and a state where the rubber stopper 4000 and the protective part 3000 are removed before being coupled to a vial. Referring to (a) of FIG. 10, the medicine mixing unit 1000 is coupled to the syringe S in a coupled state with the rubber stopper 4000 and the protective part 3000, and as shown in (b) of FIG. 10, the medicine mixing unit 1000 can be used by removing the rubber stopper 4000 and the protective part 3000 just before fastening the spike needle 140 to the vial.
[0088] 11 is a diagram illustrating a drug mixing unit 1000, a gripping part 2000, a protective part 3000, a rubber stopper 4000, and a syringe S according to an embodiment of the present invention. As arranged in the drawing, in the order of adjacent configuration, the drug mixing unit 1000, the gripping part 2000, the protective part 3000, the rubber stopper 4000, and the syringe S may be coupled by an interfitting type or a rotational coupling type using a screw thread, etc.
[0089] FIG. 12 is a time-series diagram illustrating how the medicine mixing unit 1000 according to the embodiment of the present invention is coupled to a vial after the gripping part 2000, the protective part 3000, the rubber stopper 4000, and the upper cap are coupled together.
[0090] Since the drug mixing unit 1000 according to the embodiment of the present invention stores drugs in advance before being combined with the syringe S for use, it is preferable that the drug mixing unit 1000 according to the embodiment of the present invention is isolated from the outside air, etc. For this reason, the drug mixing unit 1000 according to the embodiment of the present invention may further include an upper cap for blocking the second flow path 20 from the outside air. Referring to (a) and (b) of Figure 12, it can be seen that the upper cap combined with the drug mixing unit 1000 according to the embodiment of the present invention is separated just before use.
[0091] FIG. 12 shows the state up to the stage of fastening to the vial, in which the top cap is removed from the protruding coupling portion 250, the syringe S is coupled to the removed protruding coupling portion 250, and then the protective portion 3000 and the gripping portion 2000 are removed, and the gripping portion 2000 is coupled to the top cap of the vial.
[0092] Next, FIG. 13 is a diagram illustrating, in a time sequence, the state in which the gripping part 2000 is attached to the drug mixing unit 1000 according to an embodiment of the present invention and is coupled to a vial, the drug liquid moves to the cylinder of the syringe S, and the state in which a stopper member is coupled to seal the mixed drug from the outside air before final use.
[0093] In order to prevent the drug from leaking out, it is preferable that the drug-mixing unit 1000 is moved downwards while positioned above the ground level of the vial until it is fastened to the vial.
[0094] 13(h) shows a state in which the liquid medicine in the vial moves as the plunger of the syringe S moves upward from the ground. However, this is not limited to this, and a method of moving the liquid medicine into the cylinder of the syringe S by tilting the syringe S or positioning the vial higher than the syringe S may be used, taking into consideration the size of the vial, the amount of liquid medicine contained in the vial, and the spatial positions of the openings 40a, 40b, 40c... formed in the spike needle 140 after they are inserted into the vial.
[0095] Referring to Figures 13(h) to (l), it can be seen that after the mixed medicine is filled into the cylinder of the syringe S, the airtight stopper can be tightened and the mixed medicine in the syringe S can be stored in a state blocked from contact with the outside air until it is used.
[0096] In the present specification and drawings, preferred embodiments of the present invention are disclosed, and even if specific terms are used, these are used in a general sense merely to clearly explain the technical contents of the present invention and to aid in the understanding of the invention, and are not intended to limit the scope of the present invention. In addition to the embodiments disclosed herein, it is obvious to those having ordinary skill in the art to which the present invention pertains that other modifications based on the technical concept of the present invention can be implemented.
Claims
1. a barrel member having a first flow passage formed therein through which the drug solution is drawn; a plug member having an insertion portion inserted into the barrel member, a second flow path through which the mixed medicine is drawn into the inside of the insertion portion, and a through hole connected to the second flow path formed on one side of the insertion portion; the plug member is coupled with the barrel member to form a predetermined drug mixing space; The drug mixing space is provided with a drug to be mixed with the drug solution introduced through the first flow path to form the mixed drug, A third flow path is formed on an inner surface of the barrel member through which the mixed medicine moves from the medicine mixing space to the through hole; The barrel member has a protruding spike needle that forms the first flow passage on one outer surface thereof, The spike needle has a plurality of openings on an outer surface thereof connected to the first flow passage, The opening is a long hole extending along the longitudinal direction of the spike needle, The first flow passage is configured to have a wider radius adjacent to an inner bottom surface of the barrel member, The drug mixing space forms a spiral path from a predetermined position separated from the first flow path to the third flow path, the helical path is defined by a continuous partition wall extending from the inner bottom surface of the barrel member to the outer bottom surface of the insertion portion of the plug member; the second flow path is coupled to a syringe that provides a negative pressure through which the drug solution is drawn; The first flow path, the second flow path, and the third flow path are not directly connected to each other, The length of the long hole in the longitudinal direction is greater than the inner diameter of the first flow passage, The inner diameter of the through hole is larger than the inner diameter of the first flow path and smaller than the inner diameter of the second flow path, A drug mixing unit, characterized in that an inner diameter of the third flow path is larger than an inner diameter of the first flow path and smaller than an inner diameter of the through hole.
2. The drug mixing unit according to claim 1 , wherein the plug member has a protruding coupling portion that defines the second flow passage.
3. The drug mixing unit according to claim 1 , wherein the through-hole and the third flow path are disposed at a predetermined distance from each other.
4. The medicine mixing unit includes a protection portion into which the barrel member is inserted and supported, the protection portion being provided to isolate the first flow path from outside air; The drug mixing unit according to claim 1, further comprising an undercap having a gripping portion integrally formed with the protection portion and for fixing and supporting an upper cap of a vial in which the drug solution is stored.
5. The drug mixing unit according to claim 1 , further comprising an upper cap for isolating the second flow path from outside air.
6. The medicine mixing unit according to claim 1 , further comprising a rubber stopper into which the spike needle is inserted and supported to block the first flow path from outside air.
7. 2. The drug mixing unit according to claim 1, wherein the first flow path is formed to protrude from the inner bottom of the barrel member by a predetermined height, but is formed at a height lower than the lower end surface of the insertion portion of the plug member.
8. The drug mixing unit according to claim 1, wherein the drug is a liquid drug, a powder drug or a granular drug.
9. The drug mixing unit according to claim 1, wherein the plug member and the barrel member are coupled to each other by a projection and recess for supporting each other, or are coupled to each other by a rotational coupling type using a screw thread.
10. The support portion is provided to have an outer diameter larger than that of the insertion portion, The drug mixing unit according to claim 1, further comprising a silicon ring member between the insertion portion and the support portion of the plug member for blocking the outside air when the plug member is coupled to the barrel member.
Citation Information
Patent Citations
JP1978074996U
medical bag
JP1992071939U
Compact pharmaceutical reshaping apparatus and method
JP2014505546A
Solution delivery devices and methods
JP2017527427A
Syringe for mixing of materials separate kept
KR1020110041826A
